Results 51 to 60 of about 539,828 (207)

Pulmonary vascular imaging characteristics after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

, 2020
BACKGROUND: Between 16% and 51% of patients with chronic thromboembolic pulmonary hypertension will have residual pulmonary hypertension (PH) after pulmonary endarterectomy (PEA).
de Man, Frances S., Symersky, Petr, Bogaard, Harm Jan, Marcus, J. Tim, Lely, Rutger J., Klok, Frederikus A., Schokker, Monique G.M., Beijk, Marcel A.M., Braams, Natalia J., Schokker, Monique G. M., Vonk Noordegraaf, Anton, Nossent, Esther J., Ruigrok, Dieuwertje, Meijboom, Lilian J., Huisman, Menno V., Beijk, Marcel A. M., Padervinskiene, Lina   +16 more
core   +1 more source

The outcome of reoperative pulmonary endarterectomy surgery [PDF]

Interactive CardioVascular and Thoracic Surgery, 2018
OBJECTIVES: Pulmonary endarterectomy (PEA) is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension (PH). Despite excellent outcomes following PEA, a small proportion of patients have residual proximal disease or present with recurrent chronic thromboembolic PH and may benefit from further surgery.
Ali, Jason M, Dunning, John, Ng, Choo, Tsui, Steven, Cannon, John E, Sheares, Karen K, Taboada, Dolores, Toshner, Mark, Screaton, Nick, Pepke-Zaba, Joanna, Jenkins, David P   +10 more
openaire   +3 more sources

Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism [PDF]

, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but feared long-term complication of acute pulmonary embolism (PE), although CTEPH may occur in patients with no history of symptomatic venous thromboembolism.
M. Delcroix, Klok, F A, Bogaard, H.J., Delcroix, M., Bogaard, H J, Delcroix, M, Klok, F.A., F.A. Klok, H.J. Bogaard   +8 more
core   +1 more source

Emergent balloon pulmonary angioplasty in a patient with central‐type chronic thromboembolic pulmonary hypertension with cardiac shock

Clinical Case Reports, 2022
The standard treatment of chronic thromboembolic pulmonary hypertension (CTEPH) is pulmonary endarterectomy (PEA); however, it may be unsuitable in the presence of comorbidities such as cardiac shock and severe hypoxia.
Hiroto Tamura, Shinobu Hosokawa, Kenichiro Yuba   +2 more
doaj   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Persistent exercise intolerance after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

, 2020
AIM: Haemodynamic normalisation is the ultimate goal of pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH). However, whether normalisation of haemodynamics translates into normalisation of exercise capacity is ...
Symersky, Petr, Bogaard, Harm-Jan, Vonk Noordegraaf, Anton, Ruigrok, Dieuwertje, Nossent, Esther J, Boonstra, Anco, Braams, Natalia J, van Wezenbeek, Jessie, Meijboom, Lilian J, de Man, Frances S, Marcus, J Tim   +10 more
core   +1 more source

Decision-making in pulmonary endarterectomy surgery [PDF]

European Respiratory Journal, 2019
Clarification of certain issues related to the UK pulmonary endarterectomy referral pathway, emphasising the importance of referral of all patients with CTEPH to a surgical teamhttp://ow.ly ...
Robin, Condliffe, Syed Rehan, Quadery, David P, Jenkins, Iain J, Armstrong, David G, Kiely   +4 more
openaire   +5 more sources

Chronic post-embolic pulmonary hypertension: a new target for medical therapies? [PDF]

European Respiratory Review, 2013
The rationale for the use of pulmonary arterial hypertension-targeted drugs in chronic thromboembolic pulmonary hypertension is based on four bundles of evidence, as follows: 1) the pathobiology of the disease, with a distal component of pre-capillary ...
Marion Delcroix
doaj   +1 more source

Pulmonary endarterectomy and the cost of patient refusal [PDF]

European Respiratory Journal, 2018
The recommended treatment for operable chronic thromboembolic pulmonary hypertension is pulmonary endarterectomy, and patients who refused surgery in the current study had worse long-term survival than those who underwent surgery http://ow.ly ...
Nick H, Kim, Eckhard, Mayer
openaire   +2 more sources

Ischaemic Optic Neuropathy After Cardiac Surgery: A Systematic Review and Meta‐Analysis of Incidence and Risk Factors

ANZ Journal of Surgery, EarlyView.
Across 11 observational studies comprising 6 471 577 patients, the pooled incidence of ischaemic optic neuropathy after cardiac surgery was approximately 1.5 cases per 10 000 procedures. Coronary artery disease, peripheral vascular disease and anaemia were associated with increased odds of ION, although these findings should be interpreted in the ...
Daud Mutahar, Ammar Zaka, Amitouj S. Sidhu, Shahi Goswami, Aditi Singh, Jordan Ng, Brandon Stretton, Joshua G. Kovoor, Aashray K. Gupta, Stephen Bacchi, Weng Onn Chan, Celia Chen   +11 more
wiley   +1 more source